Miscellany Complications of ERCP

  • Zito Francesco Paolo
  • Germani Ugo
  • D’ Alessandro Alessandra
  • Zullo Angelo
  • Raffaele Manta


As shown in previous chapters, pancreatitis, bleeding, and perforation represent the most common adverse events following endoscopic retrograde cholangiopancreatography ERCP. However, there is a very wide range of other ERCP-related complications which occasionally may occur, such as post-procedural infections (cholangitis and cholecystitis), pneumothorax, hepatic hematomas, air embolism, splenic injury, basket/stent impaction, and other very uncommon complications. Although rare, these adverse events may be potentially life-threatening and difficult to be promptly diagnosed since the symptomatic onset is very similar at the beginning. Moreover, there is a large body of evidence showing that the occurrence of unusual complications is not predictable, even by skilled operators, and challenging to be managed.


Infectious complications Bacteremia Cholangitis Cholecystitis Post-ERCP adverse events Hepatic hematoma Splenic injury Hepatic abscess 


  1. 1.
    Miyatani H, et al. Post-ERCP biliary complications in patients with biliary type sphincter of Oddi dysfunction. Sci Rep. 2018;8(1):9951. Scholar
  2. 2.
    Freeman ML, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335(13):909–18. Scholar
  3. 3.
    Kahaleh M, Freeman M. Prevention and management of post-endoscopic retrograde cholangiopancreatography complications. Clin Endosc. 2012;45(3):305–12. Scholar
  4. 4.
    Chandrasekhara V, et al. Adverse events associated with ERCP. Gastrointest Endosc. 2017;85(1):32–47. Scholar
  5. 5.
    Kwon CI, et al. Unusual complications related to endoscopic retrograde cholangiopancreatography and its endoscopic treatment. Clin Endosc. 2013;46(3):251–9. Scholar
  6. 6.
    Guda ML, Nalini FL. Overview of ERCP complications: prevention and management. ERCP and EUS. Springer Science; 2015.
  7. 7.
    ASGE Quality Assurance in Endoscopy Committee, Calderwood AH, et al. ASGE guideline for infection control during GI endoscopy. Gastrointest Endosc. 2018;87(5):1167–79. Scholar
  8. 8.
    Vila JJ, et al. Post-endoscopic retrograde cholangiopancreatography complications: how can they be avoided? World J Gastrointest Endosc. 2012;4(6):241–6. Scholar
  9. 9.
    Petersen BT, et al. Infection using ERCP endoscopes. Gastroenterology. 2016;151(1):46–50. Scholar
  10. 10.
    Cheng CL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139–47.CrossRefGoogle Scholar
  11. 11.
    Vandervoort J, et al. Risk factors for complic-ations after performance of ERCP. Gastrointest Endosc. 2002;56:652–6.CrossRefGoogle Scholar
  12. 12.
    Masci E, et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96:417–23.CrossRefGoogle Scholar
  13. 13.
    Wang P, et al. Risk factors for ERCP-related complications: a prospective multicenter study. Am J Gastroenterol. 2009;104:31–40.CrossRefGoogle Scholar
  14. 14.
    Katsinelos P, et al. Risk factors for therapeutic ERCP-related complications: an analysis of 2,715 cases performed by a single endoscopist. Ann Gastroenterol. 2014;27:65–72.PubMedPubMedCentralGoogle Scholar
  15. 15.
    Du M, et al. Post-ERCP infection and its epidemiological and clinical characteristics in a large Chinese tertiary hospital: a 4-year surveillance study. Antimicrob Resist Infect Control. 2017;6:131. Scholar
  16. 16.
    Talukdar R. Complications of ERCP. Best Pract Res Clin Gastroenterol. 2016;30(5):793–805. Scholar
  17. 17.
    Beilenhoff U, et al. Prevention of multidrug-resistant infections from contaminated duodenoscopes: position statement of the European Society of Gastrointestinal Endoscopy (ESGE) and European Society of Gastroenterology Nurses and Associates (ESGENA). Endoscopy. 2017;49(11):1098–106. Scholar
  18. 18.
    Kwak MS, et al. Risk factors of post- endoscopic retrograde cholangiopancreatography bacteremia. Gut Liver. 2013;7(2):228–33. Scholar
  19. 19.
    Kim MH, et al. The impact of gallbladder status on biliary complications after the endoscopic removal of choledocholithiasis. Dig Dis Sci. 2016;61(4):1165–71. Scholar
  20. 20.
    Smith ZL, et al. Transmission of carbapenem-resistant Enterobacteriaceae during ERCP: time to revisit the current reprocessing guidelines. Gastrointest Endosc. 2015;81(4):1041–5. Scholar
  21. 21.
    Alfa MJ, et al. A survey of reprocessing methods, residual viable bioburden, and soil levels in patient-ready endoscopic retrograde cholangiopancreatography duodenoscopes used in Canadian centers. Infect Control Hosp Epidemiol. 2002;23:198–206.CrossRefGoogle Scholar
  22. 22.
    Kola A, et al. An outbreak of carbapenem-resistant OXA-48—producing Klebsiella pneumonia associated to duodenoscopy. Antimicrob Resist Infect Control. 2015;4:8. Scholar
  23. 23.
    Wendorf KA, et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol. 2015;36:634–42.CrossRefGoogle Scholar
  24. 24.
    Robertson P, et al. Transmission of Salmonella enteritidis after endoscopic retrograde cholangiopancreatography because of inadequate endoscope decontamination. Am J Infect Control. 2017;45(4):440–2. Scholar
  25. 25.
    Chen M, et al. Risk factor analysis of post-ERCP cholangitis: a single-center experience. Hepatobiliary Pancreat Dis Int. 2018;17(1):55–8. Scholar
  26. 26.
    Freeman ML. Complications of endoscopic retrograde cholangiopancreatography: avoidance and management. Gastrointest Endosc Clin North Am. 2012;22:567–86.CrossRefGoogle Scholar
  27. 27.
    Kostrzewska M, et al. Complications of endoscopic retrograde cholangio-pancreatography (ERCP) and their risk factors. Adv Med Sci. 2011;56:6–12.CrossRefGoogle Scholar
  28. 28.
    Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Am. 2000;14:521–46.CrossRefGoogle Scholar
  29. 29.
    Tierney J, et al. Predictive risk factors associated with cholangitis following ERCP. Surg Endosc. 2018;32(2):799–804. Scholar
  30. 30.
    Buxbaum JL, et al. Inoperable pancreatic cancer patients who have prolonged survival exhibit an increased risk of cholangitis. JOP. 2011;12(4):377–83.PubMedPubMedCentralGoogle Scholar
  31. 31.
    Pola S, et al. Long-term risk of cholangitis in patients with metal stents for malignant biliary obstruction. Dig Dis Sci. 2012;57(10):2693–6.CrossRefGoogle Scholar
  32. 32.
    Glomsaker T, et al. Patterns and predictive factors of complications after endoscopic retrograde cholangiopancreatography. Br J Surg. 2013;100:373–80.CrossRefGoogle Scholar
  33. 33.
    Agostoni M, et al. Adverse events during monitored anesthesia care for GI endoscopy: an 8-year experience. Gastrointest Endosc. 2011;74:266–75.CrossRefGoogle Scholar
  34. 34.
    Zappa MA, Aiolfi A, Antonini I, Musolino CD, Porta A. Subcapsular hepatic haematoma of the right lobe following endoscopic retrograde cholangiopancreatography: case report and literature review. World J Gastroenterol. 2016;22(17):4411–5. Scholar
  35. 35.
    Imperatore N, et al. Systematic review: features, diagnosis, management and prognosis of hepatic hematoma, a rare complication of ERCP. Dig Liver Dis. 2018;50(10):997–1003. Scholar
  36. 36.
    Ortega Deballon P, et al. Liver hematoma following endoscopic retrograde cholangiopancreatography (ERCP). Surg Endosc. 2000;14:767.CrossRefGoogle Scholar
  37. 37.
    Horn TL, Pena LR. Subcapsular hepatic hematoma after ERCP: case report and review. Gastrointest Endosc. 2004;59:594–6.CrossRefGoogle Scholar
  38. 38.
    Chi KD, Waxman I. Subcapsular hepatic hematoma after guide wire injury during endoscopic retrograde cholangiopancreatography: management and review. Endoscopy. 2004;36:1019–21.CrossRefGoogle Scholar
  39. 39.
    Liu L, et al. Pyogenic liver abscess: a retrospective study of 105 cases in an emergency department from East China. J Emerg Med. 2017;52(4):409–16.
  40. 40.
    Kalaitzakis E. All-cause mortality after ERCP. Endoscopy. 2016;48(11):987–94. Scholar
  41. 41.
    Lardiere-Deguelte S, et al. Hepatic abscess: diagnosis and management. J Visc Surg. 2015;152(4):231–43. Scholar
  42. 42.
    Peng YC, et al. Risk of pyogenic liver abscess and endoscopic sphincterotomy: a population-based cohort study. BMJ Open. 2018;8(3):e018818. Scholar
  43. 43.
    Oliveira-Cunha M, et al. Late complications after endoscopic sphincterotomy. Surg Laparosc Endosc Percutan Tech. 2016;26(1):1–5. Scholar
  44. 44.
    Pamudurthy V, et al. Etiologies and risks of splenic decapsulation after endoscopic retrograde cholangiopancreatography: case report and literature review. Endosc Int Open. 2018;6(3):E271–3. Scholar
  45. 45.
    Chawla S, Willingham FF. Cardiopulmonary complications of endoscopic retrograde cholangiopancreatography. Tech Gastrointest Endosc. 2014;16:144–9.CrossRefGoogle Scholar
  46. 46.
    Sharma VK, et al. A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc. 2007;66:27–34.CrossRefGoogle Scholar
  47. 47.
    El Hajj II, et al. Life threatening hemobilia after endoscopic retrograde cholangiopancreatography (ERCP). Dig Liver Dis. 2017;49(12):1336–7. Scholar
  48. 48.
    Fujii L, et al. Successful nonsurgical treatment of pneumomediastinum, pneumothorax, pneumoperitoneum, pneumoretroperitoneum, and subcutaneous emphysema following ERCP. Gastroenterol Res Pract. 2010;2010:289135. Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Zito Francesco Paolo
    • 1
  • Germani Ugo
    • 2
  • D’ Alessandro Alessandra
    • 1
  • Zullo Angelo
    • 3
  • Raffaele Manta
    • 2
  1. 1.Digestive Endoscopy UnitPineta Grande HospitalCasertaItaly
  2. 2.Digestive Endoscopy UnitUniversity Hospital of PerugiaPerugiaItaly
  3. 3.Gastroenterology and Digestive Endoscopy Unit of Nuovo Regina Margherita HospitalRomeItaly

Personalised recommendations